Documentos relacionados

1. Preliminary experience of maintenance treatment with intravenous ustekinumab as a rescue treatment for loss of response to subcutaneous doses.
2. Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
3. Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing.
4. Single or continuous multiple intravenous re-induction in Crohn's disease patients who lost response to ustekinumab: Evidence from real-world data.
5. Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group.
6. Ustekinumab IV 6 mg/kg Loading Dose Re-induction Improves Clinical and Endoscopic Response in Crohn's disease: A Case Series.
7. Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
8. Clinical Decision Support Tool for Infliximab in Crohn's Disease.
9. Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn Disease (the Speed-up Study): A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN.
10. Efficacy and safety of intravenous ustekinumab maintenance therapy in Crohn's disease.